Loading Programs

Available Programs > Online On-Demand

Programs Search and Views Navigation

November 2020

  • ONLINE ON-DEMAND

STAYING AHEAD of the CURVE: New Therapeutic Agents in AML

November 20, 2020 - February 20, 2021

The incidence of acute myeloid leukemia (AML) has increased due to an aging population, risk from environmental exposures, and treatment-related/secondary AML in survivors of young and childhood cancers. Members of the hematology/oncology care team are challenged to keep apprised of clinical data, incorporate novel agents into their clinical practice, and manage side effects of newer therapies. In this activity, Dr Daniel Pollyea and Dr Amer Zeidan provide expert commentary on 2 challenging clinical case scenarios focused on management of AML.…

Find out more »
  • ONLINE ON-DEMAND

Following the Trial of Evidence to Individualize and Optimize Multiple Sclerosis Care – Gather-ed Activity

November 1, 2020 - November 1, 2021

The goal of this Gather-ed experience is to summarize the latest clinical evidence and recommendations for early diagnosis and aggressive management of MS. This initiative consists of self-study modules and live group discussions that briefly review relevant clinical trial findings and addresses questions clinicians commonly face in their practice.

Find out more »

September 2020

  • ONLINE ON-DEMAND

Advances in the Multidisciplinary Care of Patients with Tenosynovial Giant Cell Tumor – Gather-ed Activity

September 21, 2020 - September 21, 2021

Tenosynovial giant cell tumor (TGCT), a rare, nonmalignant tumor, arises from synovium in joints, bursae, and tendon sheaths. The diffuse type often presents aggressively, with high recurrence rates following surgery. The FDA recently approved the first medication for adult patients with symptomatic TGCT associated with severe morbidity or functional limitations and not amenable to improvement with surgery. Individualized treatment plans should be created for patients by evaluating the benefits and risks of surgery and medications, as well as the type…

Find out more »
  • ONLINE ON-DEMAND

Matching the Tool to the Job: Individualizing Treatment Strategies in Ovarian Cancer

September 1, 2020 - September 1, 2021

How have PARP inhibitors changed maintenance therapy for advanced ovarian cancer? Join Dr Michael Birrer and Dr Ursula Matulonis as they discuss recent clinical data related to the use of PARP inhibitors in maintenance therapy for advanced ovarian cancer, and highlight strategies to effectively prevent and manage treatment-related adverse effects. This activity is jointly provided by Postgraduate Institute for Medicine and Spire Learning. This activity is supported by an independent educational grant from Tesaro, a GSK company. Click on this link to access…

Find out more »
  • ONLINE ON-DEMAND

The Who, What, When & Why of Maintenance Therapy in Ovarian Cancer

September 1, 2020 - September 1, 2021

How have PARP inhibitors changed maintenance therapy for advanced ovarian cancer? Join Dr Michael Birrer and Dr Ursula Matulonis as they discuss recent clinical data related to the use of PARP inhibitors in maintenance therapy for advanced ovarian cancer, and highlight strategies to effectively prevent and manage treatment-related adverse effects. This activity is jointly provided by Postgraduate Institute for Medicine and Spire Learning. This activity is supported by an independent educational grant from Tesaro, a GSK company.   Click on this link to…

Find out more »

July 2020

  • ONLINE ON-DEMAND

A Novel Therapeutic Approach in Myeloid Malignancies: Targeting the Neddylation Pathway

July 28, 2020 - July 28, 2021

There is a lack of therapeutic options for the management of myeloid malignancies. So what are some emerging therapies that are available to patients? Join Mikkael A. Sekeres, MD, MS, and Sara M. Tinsley, PhD, ARNP, AOCNP during this podcast discussion and find out what novel therapeutic approaches are being evaluated for myeloid malignancies. This activity is jointly provided by Albert Einstein, Montefiore, and Spire Learning. This activity is supported by an independent educational grant from Takeda Oncology. Click on…

Find out more »

June 2020

  • ONLINE ON-DEMAND

Collaborating to Overcome Lifelong Challenges in Hemophilia A: Prophylaxis, Inhibitors, and Treatment Burden – A Gather-ed Activity

June 5, 2020 - June 4, 2021

This online CME program was developed to help clinicians create personalized treatment plans, utilize strategies to improve adherence, and implement plans for management of inhibitors in patients with hemophilia A. This Gather-ed is supported with self-study modules, live web discussions, and collaborative group tasks. The intent is to provide participants with an opportunity to improve their understanding of clinical information and to share experiences with peers. Online Gather-ed Peer-to-Peer Learning and Mentoring Initiative

Find out more »
  • ONLINE ON-DEMAND

Joint Decision-Making in the Treatment of Tenosynovial Giant Cell Tumors: Balancing Benefits and Risks

June 3, 2020 - June 3, 2021

Tenosynovial giant cell tumor (TGCT) is a rare, nonmalignant tumor affecting the synovial lining of joints, bursae, and tendon sheaths. It is a potentially locally aggressive disease with high recurrence rates. In addition to agents used off-label for TGCT, the FDA recently approved the first medication specifically indicated for adult patients with symptomatic TGCT associated with severe morbidity or functional limitations and not amenable to improvement with surgery. This educational activity will ensure clinicians are better informed of the benefits…

Find out more »

May 2020

  • ONLINE ON-DEMAND

Balance the Scales: Immuno-Oncology Combination Therapies in Advanced RCC

May 14, 2020 - May 14, 2021

Improved understanding of renal cell carcinoma (RCC) has led to the recent approval of immuno-oncology therapies (IOs) that can be used in combination with other IOs or with vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs). In this interactive webinar experts in RCC discuss IO combinations in RCC, including the rationale for development, clinical trial data, and safety considerations concerning immune-related adverse events. This activity includes interactive polling questions interspersed throughout the activity to engage learners and facilitate application…

Find out more »
  • ONLINE ON-DEMAND

Influenza Frontline Management and Prevention Podcast

May 14, 2020 - May 14, 2021

Seasonal influenza has a significant socioeconomic impact, with several patient populations at high risk of complications. This podcast will provide the latest updates in the prevention and management of influenza and insights into opportunities for improved patient care, considerations for diagnostic testing, and efficacy and safety of antivirals. https://learning.freecme.com/a/34424P2N9tAD  

Find out more »
  • ONLINE ON-DEMAND

Put It in Reverse: Managing Oral Anticoagulant-Associated Bleeds

May 14, 2020 - May 14, 2021

An increasing number of people are taking oral anticoagulants (OACs), and major bleeds or emergent surgeries in these individuals are a challenge to safely and effectively manage. Newer reversal agents that target direct oral anticoagulants have changed the treatment landscape. Clinicians must assess each case and consider the most recent evidence on reversal strategies to recommend an optimal treatment plan. This 30-minute, certified activity will address important clinical issues related to managing bleeds in patients receiving OACs, including evaluating bleed…

Find out more »

April 2020

  • ONLINE ON-DEMAND

What’s New in Eczema Management: Practice Pearls for the Family Physician

April 30, 2020 - April 30, 2021

Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease with a lifetime prevalence of 10% to 20% in children and 1% to 3% in adults. It is the most common pediatric skin disease and primary care providers (PCPs) are often the first point of contact for the diagnosis and management of AD symptoms. As many as 70% of patients with mild to moderate disease can be managed in the primary care setting. This case activity addresses the latest in…

Find out more »

March 2020

  • ONLINE ON-DEMAND

Practical Approaches for MS Infusion Therapies

March 23, 2020 - April 30, 2021

Treatment selection and modification in MS can be a complex, daunting problem for MS care providers. Enjoy active discussion with your colleagues and get expert insight into optimizing outcomes for your patients on infusible MS therapies! Join us to discuss thought-provoking, real-world cases with your peers and a clinical expert in MS. This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC), the International Organization of Multiple Sclerosis Nurses (IOMSN), and Spire Learning. This activity is supported by…

Find out more »

November 2019

  • ONLINE ON-DEMAND

Straight to the Source: Top Questions Hospital Pharmacists Will Receive About Reversal of Factor Xa Inhibitors

November 27, 2019 - November 27, 2020

Direct factor Xa (FXa) inhibitors (rivaroxaban, apixaban, edoxaban, and betrixaban) have become the most widely utilized class of anticoagulants in the United States. Due to their expertise in managing anticoagulation and their role as the drug information experts, pharmacists are critically important in assuring the correct FXa inhibitor is being used in the correct indication, at the correct dose, with detailed patient education to maximize positive patient outcomes. They must also be able to recognize and manage bleeds that are…

Find out more »
+ Export Events